Report Detail
Global Intrathecal Drug Market Insights, Forecast to 2025
- RnM2683551 |
- 04 June, 2019 |
- Global |
- 119 Pages |
- QYResearch |
- Pharma & Healthcare
Intrathecal administration is a route of administration for drugs via an injection into the spinal canal, or into the subarachnoid space so that it reaches the cerebrospinal fluid (CSF) and is useful in spinal anaesthesia, chemotherapy, or pain management applications. This route is also used to introduce drugs that fight certain infections, particularly post-neurosurgical. The drug needs to be given this way to avoid being stopped by the blood brain barrier. The same drug given orally must enter the blood stream and may not be able to pass out and into the brain. Drugs given by the intrathecal route often have to be compounded specially by a pharmacist or technician because they cannot contain any preservative or other potentially harmful inactive ingredients that are sometimes found in standard injectable drug preparations.
The global Intrathecal Drug market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Intrathecal Drug market based on company, product type, end user and key regions.
This report studies the global market size of Intrathecal Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Intrathecal Drug in these regions.
This research report categorizes the global Intrathecal Drug market by top players/brands, region, type and end user. This report also studies the global Intrathecal Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Medtronic
Jazz Pharmaceuticals
West Ward Pharmaceutical
Saol Therapeutics
Piramal Critical Care
Fresenius Kabi
Market size by Product
Baclofen injection
Ziconotide Intrathecal Infusion
Morphine injection
Market size by End User
Adult
Child & Teen
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Intrathecal Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Intrathecal Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Intrathecal Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Intrathecal Drug submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Intrathecal Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Intrathecal Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Intrathecal Drug Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Intrathecal Drug Market Size Growth Rate by Product
- 1.4.2 Baclofen injection
- 1.4.3 Ziconotide Intrathecal Infusion
- 1.4.4 Morphine injection
- 1.5 Market by End User
- 1.5.1 Global Intrathecal Drug Market Size Growth Rate by End User
- 1.5.2 Adult
- 1.5.3 Child & Teen
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Intrathecal Drug Market Size
- 2.1.1 Global Intrathecal Drug Revenue 2014-2025
- 2.1.2 Global Intrathecal Drug Sales 2014-2025
- 2.2 Intrathecal Drug Growth Rate by Regions
- 2.2.1 Global Intrathecal Drug Sales by Regions
- 2.2.2 Global Intrathecal Drug Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Intrathecal Drug Sales by Manufacturers
- 3.1.1 Intrathecal Drug Sales by Manufacturers
- 3.1.2 Intrathecal Drug Sales Market Share by Manufacturers
- 3.1.3 Global Intrathecal Drug Market Concentration Ratio (CR5 and HHI)
- 3.2 Intrathecal Drug Revenue by Manufacturers
- 3.2.1 Intrathecal Drug Revenue by Manufacturers (2014-2019)
- 3.2.2 Intrathecal Drug Revenue Share by Manufacturers (2014-2019)
- 3.3 Intrathecal Drug Price by Manufacturers
- 3.4 Intrathecal Drug Manufacturing Base Distribution, Product Types
- 3.4.1 Intrathecal Drug Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Intrathecal Drug Product Type
- 3.4.3 Date of International Manufacturers Enter into Intrathecal Drug Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Intrathecal Drug Sales by Product
- 4.2 Global Intrathecal Drug Revenue by Product
- 4.3 Intrathecal Drug Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Intrathecal Drug Breakdown Data by End User
6 North America
- 6.1 North America Intrathecal Drug by Countries
- 6.1.1 North America Intrathecal Drug Sales by Countries
- 6.1.2 North America Intrathecal Drug Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Intrathecal Drug by Product
- 6.3 North America Intrathecal Drug by End User
7 Europe
- 7.1 Europe Intrathecal Drug by Countries
- 7.1.1 Europe Intrathecal Drug Sales by Countries
- 7.1.2 Europe Intrathecal Drug Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Intrathecal Drug by Product
- 7.3 Europe Intrathecal Drug by End User
8 Asia Pacific
- 8.1 Asia Pacific Intrathecal Drug by Countries
- 8.1.1 Asia Pacific Intrathecal Drug Sales by Countries
- 8.1.2 Asia Pacific Intrathecal Drug Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Intrathecal Drug by Product
- 8.3 Asia Pacific Intrathecal Drug by End User
9 Central & South America
- 9.1 Central & South America Intrathecal Drug by Countries
- 9.1.1 Central & South America Intrathecal Drug Sales by Countries
- 9.1.2 Central & South America Intrathecal Drug Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Intrathecal Drug by Product
- 9.3 Central & South America Intrathecal Drug by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Intrathecal Drug by Countries
- 10.1.1 Middle East and Africa Intrathecal Drug Sales by Countries
- 10.1.2 Middle East and Africa Intrathecal Drug Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Intrathecal Drug by Product
- 10.3 Middle East and Africa Intrathecal Drug by End User
11 Company Profiles
- 11.1 Medtronic
- 11.1.1 Medtronic Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Medtronic Intrathecal Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Medtronic Intrathecal Drug Products Offered
- 11.1.5 Medtronic Recent Development
- 11.2 Jazz Pharmaceuticals
- 11.2.1 Jazz Pharmaceuticals Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Jazz Pharmaceuticals Intrathecal Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Jazz Pharmaceuticals Intrathecal Drug Products Offered
- 11.2.5 Jazz Pharmaceuticals Recent Development
- 11.3 West Ward Pharmaceutical
- 11.3.1 West Ward Pharmaceutical Company Details
- 11.3.2 Company Business Overview
- 11.3.3 West Ward Pharmaceutical Intrathecal Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 West Ward Pharmaceutical Intrathecal Drug Products Offered
- 11.3.5 West Ward Pharmaceutical Recent Development
- 11.4 Saol Therapeutics
- 11.4.1 Saol Therapeutics Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Saol Therapeutics Intrathecal Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Saol Therapeutics Intrathecal Drug Products Offered
- 11.4.5 Saol Therapeutics Recent Development
- 11.5 Piramal Critical Care
- 11.5.1 Piramal Critical Care Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Piramal Critical Care Intrathecal Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Piramal Critical Care Intrathecal Drug Products Offered
- 11.5.5 Piramal Critical Care Recent Development
- 11.6 Fresenius Kabi
- 11.6.1 Fresenius Kabi Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Fresenius Kabi Intrathecal Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Fresenius Kabi Intrathecal Drug Products Offered
- 11.6.5 Fresenius Kabi Recent Development
12 Future Forecast
- 12.1 Intrathecal Drug Market Forecast by Regions
- 12.1.1 Global Intrathecal Drug Sales Forecast by Regions 2019-2025
- 12.1.2 Global Intrathecal Drug Revenue Forecast by Regions 2019-2025
- 12.2 Intrathecal Drug Market Forecast by Product
- 12.2.1 Global Intrathecal Drug Sales Forecast by Product 2019-2025
- 12.2.2 Global Intrathecal Drug Revenue Forecast by Product 2019-2025
- 12.3 Intrathecal Drug Market Forecast by End User
- 12.4 North America Intrathecal Drug Forecast
- 12.5 Europe Intrathecal Drug Forecast
- 12.6 Asia Pacific Intrathecal Drug Forecast
- 12.7 Central & South America Intrathecal Drug Forecast
- 12.8 Middle East and Africa Intrathecal Drug Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Intrathecal Drug Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Intrathecal Drug . Industry analysis & Market Report on Intrathecal Drug is a syndicated market report, published as Global Intrathecal Drug Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Intrathecal Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
